Palgan, Angelyn L.
HRN: 13-83-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2022
CEFUROXIME 500MG (TAB)
09/15/2022
09/22/2022
ORAL
1 Tab
BID
S/P LTCS With BTL
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes